In rare move, Colombia issues compulsory license for HIV medicine in effort to expand access

25 Apr 2024
endpts.com
Clinical Study
The Colombian government on Wednesday issued a compulsory license for a commonly used drug to treat HIV, the first time the government there has stepped in to manufacture a drug without the drugmaker’s permission.
The compulsory license was issued for dolutegravir, which is manufactured by ViiV Healthcare, an HIV-focused drug company operated by GSK. The license gives Colombia’s ministry of health the authority to manufacture the drug under a system established by a World Trade Organization agreement.
In rare move, Colombia issues compulsory license for HIV medicine in effort to expand access
Preview
Source: EndPoints
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
SIGN UP
LOG IN
BECOME A PREMIUM SUBSCRIBER
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
-
Targets
-
Drugs
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.